GM-CSF secreting leukemia cell vaccinations after allogeneic non-myeloablative peripheral blood stem cell transplantation in patients with advanced myelodysplastic syndrome or refractory acute or advanced chronic myeloid leukaemia.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Leukaemia vaccine (Primary)
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- 04 Mar 2014 Biomarkers information updated
- 15 Mar 2012 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 15 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.